Cite

HARVARD Citation

    Shichijo, T. et al. (2022). Beneficial impact of first‐line mogamulizumab‐containing chemotherapy in adult T‐cell leukaemia‐lymphoma. British journal of haematology. pp. 983-987. [Online]. 
  
Back to record